Oaktree Specialty Lending spent last quarter proving that its credit problems were shrinking. The September-quarter report has a harder job: showing that a cleaner portfolio can stop the slide in earnings. Non-accruals fell to 1.8% of debt at fair value, the lowest in years, yet adjusted net investment income per share has eased from $0.41 to $0.37 over two quarters. Wall Street expects that drift to continue, and the gap between better credit and weaker earnings power is the central tension heading into the November 17 release.
Consensus calls for EPS of $0.34, down from $0.37 last quarter and 15% below the $0.40 earned a year ago. Revenue is forecast at $69.4 million, flat sequentially but about 10% lower than the $77.3 million reported in the year-ago quarter. In plain terms, analysts expect contraction rather than stabilization. There is no fresh formal guidance to measure against. The figure that matters most is the $0.30 base dividend set after the earlier rebase. At $0.34, coverage would still be comfortable, though the cushion available for supplemental payouts would get thinner.
The previous call offered reasons to think the earnings decline should be nearing a floor, and this report should test each one. Thrasio returned to accrual after repaying roughly 80% of its loans, and management expected the remainder to be repaid in the coming months. A full quarter of income from that position, plus confirmation of the final paydown, would support the turnaround story. New-deal yields rose from 9.0% to 10.0% across three quarters, and the pipeline was being priced at SOFR plus 550 to 575 basis points, well above the tights of a year ago. If those economics are showing up in the portfolio's weighted yield, the case for an earnings trough gets stronger. The ZeoGroup fiber financing at SOFR plus 675 is an early read on whether management can find differentiated, higher-spread assets.
The counterweights are just as concrete. Leverage stood at 1.02 times, below the target midpoint, and management chose caution over deployment despite roughly $699 million of liquidity. Its talk of playing offense as a permanent-capital buyer while non-traded BDCs face redemptions needs to show up as net portfolio growth or a secondary portfolio purchase. Otherwise the earnings base will keep shrinking. Non-recurring income has been running well below its historical average, and the partial return of the incentive fee trims the bottom line. Payment-in-kind income rising to 7.8% of total investment income deserves scrutiny, because a further increase would weaken the quality of whatever earnings are reported. Investors should also look for a plan to address the $350 million of unsecured notes due in January 2027. Refinancing costs could pressure margins next year.
The market has leaned toward the credit story. Shares are up 3.1% since the last report while the S&P 500 fell 3%, and at $12.50 the stock sits above its 200-day moving average of $12.07. It trades in the upper half of a post-earnings range of $11.19 to $13.33, though not close enough to the high to suggest a breakout. Sentiment remains modestly bearish and has edged slightly more negative, to 23.4% bearish from 20.6%. That points to wariness about earnings rather than about credit.
The narrative stays intact if non-accruals hold near or below 1.8%, net asset value holds around $15.70, and investment income stops eroding even while leverage stays low. A miss accompanied by renewed markdowns, especially in the 2020 and 2021 software cohort, would suggest that last quarter's improvement was a pause rather than an inflection. The real question is whether Oaktree's cleaner balance sheet can begin producing earnings growth again, or whether caution is setting a lower ceiling for the dividend.